← Back to Search

Behavioral Intervention

Exercise Program for Fatty Liver Disease

N/A
Recruiting
Led By Jonathan G Stine, MD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights
No Placebo-Only Group

Summary

"This trial will test a new exercise program called EL-FIT on patients with a liver condition. The goal is to see if the program is safe and effective for patients with nonalcoholic steatohe

Who is the study for?
This trial is for adults over 18 with nonalcoholic steatohepatitis (NASH), confirmed by a liver biopsy or certain tests within the last 6 months. Participants must own a smartphone to use the El-Fit App, which is part of the exercise program being tested.
What is being tested?
The study is testing 'EL-FIT', a mobile health (mHealth) exercise training program designed for patients with NASH. The focus is on seeing if it's practical, safe, and acceptable when delivered through an app called El-Fit.
What are the potential side effects?
Since this trial involves an exercise program delivered via an app, side effects are minimal but may include muscle soreness or injury from physical activity. The safety aspect of the study will monitor these potential issues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of subjects that complete at least 50% of the exercise sessions

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Application Useage ArmExperimental Treatment1 Intervention
Along with wearing their Fitbit daily, subjects will be asked to use El-Fit app to participant in daily exercise as much or a little as they want over the course of the study.

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
511 Previous Clinical Trials
2,870,840 Total Patients Enrolled
5 Trials studying Non-alcoholic Fatty Liver Disease
229 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Jonathan G Stine, MDPrincipal InvestigatorPenn State Health
3 Previous Clinical Trials
52 Total Patients Enrolled
2 Trials studying Non-alcoholic Fatty Liver Disease
40 Patients Enrolled for Non-alcoholic Fatty Liver Disease
~11 spots leftby Mar 2026